Clinical trial
The Impact of Systemic Antidepressant Treatments in Early Stage on Neurocognitive Function of Euthymic Patients With Bipolar Depression
NCT04564573 is registered in ClinicalTrials.gov with Tianjin Anding Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Impact of Systemic Antidepressant Treatments in Early Stage on Neurocognitive Function of Euthymic Patients With Bipolar Depression
- Lead sponsor
- Tianjin Anding Hospital
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- July 1, 2020
- Completion date
- October 30, 2022
- Enrollment
- 124 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
bipolar disorder, cognition